key: cord-0694098-0ekjztlt
authors: Fujikawa, Tatsuya
title: Practical measures for SARS-CoV-2 infection prevention
date: 2021-12-22
journal: Lancet Infect Dis
DOI: 10.1016/s1473-3099(21)00769-6
sha: a2ef13678fb9a4c546cc5b4c308fce6a5fe75911
doc_id: 694098
cord_uid: 0ekjztlt

nan

Only a small fraction of people living in low-income countries will have received at least one dose of the SARS-CoV-2 vaccine by the end of 2021. By contrast, booster shots of the mRNA vaccines are being administered in vaccine-rich countries despite an absence of consensus regarding the need for an additional dose. 1 Adults working in high-risk settings, including healthcare workers, are currently eligible for a COVID-19 vaccine booster in some countries, including the USA, the UK, Germany, and Italy. However, the evidence supporting this policy is controversial.

Early studies documenting waning immunity to SARS-CoV-2 in mRNA vaccine recipients used antibody titres and infection rates (positive PCR test) as outcome measures; 1,2 however, no evidence was found for an appreciable waning of protection against hospital admission and death 6 months after the second dose of Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine. 2 In a recent observational study from Israel, the authors could not show the effectiveness of a third dose of BNT162b2 for preventing severe outcomes in younger age groups (16-39 years). 3 In the subgroup analysis, triple-vaccinated individuals older than 40 years had decreased rates of admission to hospital, severe disease, and COVID-19-related death compared with those who had received only two doses. In this study, individuals aged 40-69 years were stratified into the same group, which might have skewed the results, given that a third BNT162b2 vaccine dose was shown to be protective in individuals aged 60 years or older. 4 The second crucial element relates to which categories of health-care workers belong to high-risk groups. For example, the risk of testing positive for SARS-CoV-2 was greater among front-line workers (defined as those with direct patient contact) than among the general community, and the risk of hospital admission among front-door workers (defined as paramedics or workers in other acute-receiving specialities) and personnel exposed to aerosolgenerating procedures was higher than among other front-line healthcare workers. 5 However, it has also been reported that occupational risk for unvaccinated health-care providers who routinely undertake aerosol-generating procedures 6 was relatively low during the first wave of the COVID-19 pandemic, as was the risk for non-patientfacing health-care workers and their households. 5 Although expert opinion predicts that everyone will need a booster dose at some point, it would be reasonable if boosters were given only to targeted populations in whom the evidence shows they are probably needed. On a global scale, this would avoid millions of unnecessary adverse effects and, most importantly, would make those vaccines available to countries where they are most needed. After all, a worldwide epidemic-a pandemicrequires a global strategy. 

Boris Revollo and colleagues reported that a combination of same-day screening with antigen-detecting rapid diagnostic tests (Ag-RDT), wearing facemasks, and optimised air ventilation creates a safe indoor environment without the need for physical distancing. 1 I commend the authors for planning and conducting a randomised controlled trial in this serious pandemic situation. However, I would like to voice a few concerns.

First, although the protocol shows a strong intention to avoid the spread of infection, the setting appears to inadequately represent a reallife situation. Could people attend the concert in groups or was entry permitted only on an individual basis? In reality, many people may attend a concert as couples or in small groups of friends. In such cases, more conversations and contacts may occur between them, increasing the number of close contacts, and thus the risk of infection. 2 Another study estimating the risk factors for SARS-CoV-2 infection found that people closely related to the index case were at a higher risk of infection. 3 Second, during the concert, participants were instructed to wear N95 masks at all times. It is not pragmatic to provide N95 masks for every event because of their cost. 4 Moreover, if participants have difficulty breathing when they sing or dance, they may not wear their masks properly. 4 If the authors wish to recreate a situation close to real life, the use of

We appreciate the interest of Tatsuya Fujikawa in our open-label randomised study on SARS-CoV-2 transmission prevention in an indoor mass-gathering, live-music event. 1 Fujikawa wonders if people attended the concert in groups or entry was permitted only on an individual basis.

surgical masks instead of N95 masks should have been considered.

Finally, the authors suggested that all transcription-mediated amplification (TMA)-positive individuals in the intervention group were detected from among previously infected individuals who were not considered infectious. The analytical sensitivity of TMA is high, and it can confirm the presence of the SARS-CoV-2 genome in human specimens even when it is not detected by RT-PCR. 5 Furthermore, 8 days after the event, there were neither Ag-RDT nor RT-PCR positive results in the intervention group. These facts indicate that no infectious participants in the intervention group slipped through the Ag-RDT screening test, and it would be an overstatement to say that strict controls prevented the spread of the infection. Study participants were randomly assigned (1:1) to either enter the indoor live event (experimental group) or not enter the event and return to normal life (control group). 1 Randomisation was performed through a computergenerated block randomisation (REDCap module) and was stratified by age, gender, and previous COVID-19 episode. Therefore, couples or small groups of friends were split through randomisation.

Regarding the use of N95 masks instead of standard surgical masks, this study was the first time that an indoor mass-gathering-event study was allowed during the COVID-19 pandemic with no physical distancing. So, we were obliged to err on the side of caution. In addition, price differences for a single use were not relevant in Europe. All participants wore the facial mask indoors, and that was specifically controlled by the security concert crew. No one reported difficulty in breathing when singing or dancing. So, the study was performed under real-life conditions as much as possible, and the measures undertaken effectively prevented indoor SARS-CoV-2 transmission.

As Fujikawa says, transcriptionmediated amplification (TMA) is extremelly sensitive and can remain positive for weeks or even months following COVID-19 cure. Rapid antigen tests and viral cultures were able to rule out potentially infectious individuals with transmission potential among those with positive TMA tests.

We have used the same protocol of measures in a second non-randomised study with 4992 participants. 2 Using data from the centralised epidemiological surveillance system from the Catalan Public Health Department, we confirmed that there were no excess COVID-19 cases diagnosed during the subsequent 14 days after the indoor concert among concert attendees.

Finally, in a third open-label, randomised, non-inferiority study performed in another large, live, indoor gathering in Paris, France, 6678 participants were randomly allocated in a 2:1 ratio to the experimental group (attendees) or to the control group (non-attendees). 3 The authors used our same list of measures but allowed a negative rapid antigen diagnostic test performed up to 3 days before the indoor concert (we did it in the same day) and standard surgical masks. The study met the non-inferiority criterion for the primary endpoint: number of patients SARS-CoV-2positive by RT-PCR test on self-collected saliva 7 days post-gathering in the perprotocol population.

All these data suggest that the implementation of same-day antigen rapid diagnostic test screening, use of face masks, and improved ventilation can prevent high rates of SARS-CoV-2 transmission in indoor mass-gathering live concerts without physical distancing under real-life conditions.

Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial

Screening for SARS-CoV-2 antigen before a live indoor music concert: an observational study

Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial

We declare no competing interests. 

In their Article, Juliette Paireau and colleagues 1 mentioned that a change